Swedbank
NVAX icon

Swedbank’s Novavax NVAX Stock Holding History

Swedbank’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,508
Closed -$26.3K – 715
2024
Q1 		$26.3K Sell
5,508
-1,938
-26% -$8.99K ﹤0.01% 570
2023
Q4 		$35.7K Hold
7,446
– – ﹤0.01% 699
2023
Q3 		$53.9K Sell
7,446
-10
-0.1% -$80 ﹤0.01% 702
2023
Q2 		$55.4K Sell
7,456
-8
-0.1% -$63 ﹤0.01% 700
2023
Q1 		$51.7K Buy
7,464
+115
+2% +$1.06K ﹤0.01% 709
2022
Q4 		$75.5K Hold
7,349
– – ﹤0.01% 705
2022
Q3 		$134K Sell
7,349
-148
-2% -$6.41K ﹤0.01% 721
2022
Q2 		$386K Sell
7,497
-27,697
-79% -$1.43M ﹤0.01% 704
2022
Q1 		$2.59M Buy
35,194
+15,372
+78% +$1.37M ﹤0.01% 604
2021
Q4 		$3.07M Sell
19,822
-18,206
-48% -$3.13M 0.01% 603
2021
Q3 		$7.88M Buy
38,028
+31,708
+502% +$6.99M 0.01% 500
2021
Q2 		$1.34M Buy
+6,320
New +$1.16M ﹤0.01% 675

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Swedbank's NVAX Position: Q2 2024 in Review

Swedbank sold out of Novavax (NVAX) in Q2 2024, closing a stake of 5,508 shares — an estimated $26.3K sold.

Swedbank first reported a position in NVAX in Q2 2021 and held it in 12 quarters. The position peaked at $7.88M in Q3 2021. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • Swedbank reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • Swedbank sold 5,508 Novavax shares in Q2 2024, an estimated $26.3K.
  • Swedbank first reported a position in Novavax in Q2 2021 and held it in 12 quarters.
  • Swedbank's Novavax position peaked at $7.88M in Q3 2021.
  • 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on Swedbank's 13F filing for Q2 2024, filed 11 Jul 2024.